These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8909101)

  • 21. Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming.
    Kranenborg MH; Oyen WJ; Corstens FH; Oosterwijk E; van der Meer JW; Boerman OC
    J Nucl Med; 1997 Jun; 38(6):901-6. PubMed ID: 9189139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technetium-99m-antiepidermal growth factor-receptor antibody in patients with tumors of epithelial origin: part II. Pharmacokinetics and clearances.
    Iznaga-Escobar N; Torres Arocha LA; Morales Morales A; Ramos Suzarte M; Rodríguez Mesa N; Pérez Rodríguez R
    J Nucl Med; 1998 Nov; 39(11):1918-27. PubMed ID: 9829584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
    Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
    Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic effect of albendazole in experimental peritoneal hydatidosis.
    Cakmakçi M; Sayek I
    Hepatogastroenterology; 1992 Oct; 39(5):424-6. PubMed ID: 1459523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basic studies of various 99mTc-labelled renal agents and clinical application of 99mTc-malate.
    Machida T; Miki M; Ueda M; Tanaka A; Ikeda I
    Nuklearmedizin; 1977 Feb; 16(1):36-41. PubMed ID: 846865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts.
    Brekken C; Hjelstuen MH; Bruland ØS; de Lange Davies C
    Anticancer Res; 2000; 20(5B):3513-9. PubMed ID: 11131655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Labelling, control and radiopharmacological evaluation of 99mTc-adenosine 5'-diphosphate (99mTc-ADP) as tumour seeking agent.
    León AS; Rey AM; Leon ET; Savio EO; Kremer C; Lacava CJ; Nappa AN; Chiozzone RN; Campos ED
    Q J Nucl Med; 1996 Jun; 40(2):170-5. PubMed ID: 8909102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of crude hydatid cyst fluid antigens for the serological diagnosis of hydatidosis in cattle.
    Golassa L; Abebe T; Hailu A
    J Helminthol; 2011 Mar; 85(1):100-8. PubMed ID: 20587127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoimaging of arterial and venous thrombi in canine model using 99mTc labeled monoclonal antifibrin antibody.
    Ruan C; Wang Q; He G; Wu J
    Chin Med J (Engl); 1997 Jan; 110(1):69-72. PubMed ID: 9594328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of radiopharmaceuticals.
    Jánoki GA; Kerekes A
    Acta Physiol Hung; 1992; 79(2):183-96. PubMed ID: 1304681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of thrombosis with a murine anti-thrombocyte antibody (99mTc-BW 4): initial clinical results].
    Hertel A; Baum RP; Baew-Christow T; Hör G
    Nuklearmedizin; 1993 Aug; 32(4):178-82. PubMed ID: 8371999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
    Quadri SM; Vriesendorp HM
    Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality control and testing of 99mTc-macroaggregated albumin.
    Darte L; Persson BR; Söderbom L
    Nuklearmedizin; 1976 Apr; 15(2):80-5. PubMed ID: 1272817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?
    Hnatowich DJ; Virzi F; Fogarasi M; Rusckowski M; Winnard P
    Nucl Med Biol; 1994 Nov; 21(8):1035-44. PubMed ID: 9234361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting chemistry of reduction-mediated 99mTc-labelling of monoclonal antibodies and polyclonal human immunoglobulins.
    Boonkitticharoen V; Puchinda D; Ayudhya AN; Kraiphibul P
    J Med Assoc Thai; 2001 Apr; 84(4):545-53. PubMed ID: 11460967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiolabeling of cisplatin and its biodistribution in an experimental model of lung carcinogenesis.
    Rozy K; Piyali C; Chadha VD
    J Environ Pathol Toxicol Oncol; 2014; 33(1):11-7. PubMed ID: 24579806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy.
    Wingårdh K; Strand SE
    Eur J Nucl Med; 1989; 15(3):146-51. PubMed ID: 2469580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodistribution studies of anti-Thy 1.2 IgM immunoconjugates: implications for radioimmunotherapy.
    Macklis RM; Kaplan WD; Ferrara JL; Kinsey BM; Kassis AI; Burakoff SJ
    Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):383-9. PubMed ID: 3403319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.